+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07621068

Evaluating Hyperbaric Oxygen Therapy Versus Sham Treatment for Adults with Mild to Moderate Myalgic EncephalomyelitisChronic Fatigue Syndrome in a Randomized, Double-Blind Study

Led by Assaf-Harofeh Medical Center · Updated on 2026-08-21

74

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of hyperbaric oxygen therapy HBOT on adults with mild to moderate Myalgic EncephalomyelitisChronic Fatigue Syndrome MECFS. The study aims to understand how HBOT influences physical performance, cognitive function, brain imaging, and laboratory results in patients diagnosed with CFS for more than one year. This prospective, randomized, double-blind, sham-controlled study is conducted by Assaf-Harofeh Medical Center to assess treatment effects in this population. Participants will be randomly assigned to receive either HBOT or a sham treatment over a three-month period. The HBOT group will undergo 60 sessions of breathing 100% oxygen at 2 ATA pressure for 90 minutes per session, five sessions per week. The sham group will receive simulated pressure changes with breathing air at lower pressure levels, mimicking the sensation without therapeutic oxygen levels. After the treatment period, participants will be followed for an additional three months to monitor lasting effects. During the study, participants will complete various assessments including cardiopulmonary exercise tests, questionnaires on symptoms and sleep quality, cognitive tests, brain MRI and EEG scans, blood tests, muscle biopsies, and body composition measurements at baseline, post-treatment, and after the follow-up period. Sleep EEGs and orthostatic intolerance tests will also be performed at multiple time points. Researchers will track these measures to evaluate the therapys impact and safety over approximately six months of participation.

CONDITIONS

Brief Title

Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Research Team

E

Eli Kravchik, MD

S

Shai Efrati, Prof

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here